Medical Device and Diagnostics
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile


NanoString Technologies Inc. 

201 Elliott Avenue West
Suite 300
Seattle  Washington  98119  U.S.A.
Phone: 206-378-NANO Fax: 206-378-6288


 Company News
NanoString Technologies Inc. (NSTG) Announces Publication In The Journal Of Clinical Oncology Showing The Prosigna Assay Identifies Women With A Low Risk Of Late Distant Recurrence Of Breast Cancer 10/22/2014 10:46:03 AM
NanoString Technologies Inc. (NSTG) To Release Third Quarter 2014 Financial Results And Host Conference Call On Tuesday, November 4, 2014 10/10/2014 7:16:29 AM
NanoString Technologies Inc. (NSTG) Collaborates With Brigham and Women's Hospital In Boston To Accelerate Translation Of Genomic Discoveries Into Clinical Diagnostics In Oncology 10/7/2014 10:25:01 AM
NanoString Technologies Inc. (NSTG) Introduces Novel Gene Expression Panel For Immuno-Oncology Research 9/10/2014 11:36:58 AM
NanoString Technologies Inc. (NSTG) Announces Unexpected Death Of Chief Medical Officer, J. Wayne Cowens, MD 8/27/2014 8:30:44 AM
NanoString Technologies Inc. (NSTG) To Present At Upcoming Investor Conferences 8/21/2014 8:14:20 AM
NanoString Technologies Inc. (NSTG) Receives Market Approval From The Australian Therapeutic Goods Administration For Its Prosigna Breast Cancer Prognostic Gene Signature Assay 8/6/2014 10:05:49 AM
NanoString Technologies Inc. (NSTG) Releases Financial Results For Second Quarter Of 2014 8/5/2014 3:18:16 PM
NanoString Technologies Inc. (NSTG) Introduces New Universal Junction Probe Design For Detecting Gene Fusions 7/29/2014 10:10:00 AM
NanoString Technologies Inc. (NSTG), Celgene Corporation (CELG) Strike $45 Million Companion Diagnostic Pact 6/3/2014 5:00:15 PM